New Users Registration  |  Useful Links  |  FAQ  |  Site Map 
 
Go Search

 

Skip Navigation LinksHealth Xchange > News
  News  
  Categories  
     
  Chronology  
 
  2013 2014   Dec 2014 | Nov 2014 | Oct 2014 | Sep 2014 | Aug 2014 | Jul 2014 | Jun 2014 | May 2014 | Apr 2014 | Mar 2014 | Feb 2014 | Jan 2014 |
  2013   Dec 2013 | Nov 2013 | Oct 2013 | Sep 2013 | Aug 2013 | Jul 2013 | Jun 2013 | May 2013 | Apr 2013 | Mar 2013 | Feb 2013 | Jan 2013 |
  2012   Dec 2012 | Nov 2012 | Oct 2012 | Sep 2012 | Aug 2012 | Jul 2012Jun 2012May 2012Apr 2012Mar 2012 | Feb 2012 | Jan 2012 |
  2011   Dec 2011Nov 2011Oct 2011 | Sep 2011 | Aug 2011Jul 2011Jun 2011 | May 2011 | Apr 2011 | Mar 2011 | Feb 2011 | Jan 2011 |
  2010   Dec 2010 | Nov 2010 | Oct 2010 | Sep 2010 | Aug 2010 | Jul 2010 | Jun 2010 | May 2010 | Apr 2010 | Mar 2010 | Feb 2010 | Jan 2010 |
  2009   Dec 2009 | Nov 2009 | Oct 2009 | Sep 2009 | Aug 2009 |
 
     
  Topic  
 
  Health Policy and Announcements | Diseases and Outbreaks
  Medical Research | New Treatments and Technology
   
 
     
  RSS  
 
  Singapore   SingHealth | Health Promotion Board | Ministry of Health | Asiaone
  International   World Health Organization | Centre for Disease Control and Prevention (US)
       
 
     
  News Article  
 

Liberal laws ‘a boon for biomed sector’

 
  Tuesday, 03 l 08 l 2010 Source:  The Straits Times   
By: Amresh Gunasingham
     
 

US expert: S’pore still draws the best talent as it’s easier to work with embryonic stem cells here 

SINGAPORE continues to attract the best minds in biomedical research because of its comparatively liberal laws governing the use of human embryonic stem cells, a leading American scientist said here yesterday.

His comments came more than a year after United States President Barack Obama announced an easing of federal restrictions on funding stem cell work. Previous administrations had blocked such a move for years.

At the time, Mr Obama’s move was hailed as a boon for scientists in terms of reducing red tape and allowing access to restricted areas in the field.

However, it also stoked fears of a possible exodus of talent from the biomedical sector in Singapore, which has been expanding rapidly in the past decade.

But Professor Shu Chien, a famed biological scientist from the University of California (San Diego), said many US states, with the exception of some such as California, continue to impose strict restrictions on conducting research with human embryonic stem cells.

“Singapore’s laws are much more liberal in the sense that it is easier to work with embryonic stem cells,” he said.
 
Prof Shu was speaking to The Straits Times on the sidelines of the three-day International Conference On Cellular And Biomolecular Engineering at Nanyang Technological University yesterday.

The key to stem cell research is understanding master cells, which are taken from embryos, and can grow into any cell in the body.

Such cells could potentially hold a cure for ailments such as diabetes and Alzheimer’s.

But the work is controversial as the cells originate from days-old embryos, which are destroyed in the process.

Despite these restrictions, the US is still regarded as the world leader in stem cell research. At present, researchers there can seek to raise private-sector funding to conduct their work without restrictions, but Prof Shu said yesterday this often pales in comparison to the resources that could be tapped with government-aided funding.

Singapore, in contrast, has tackled the issue by embracing the research with full government support and strict laws to prevent abuse of the technology.

Speaking at the opening ceremony yesterday, Minister of State (Trade And Industry and Manpower) Lee Yi Shyan noted that a decade-long focus on investing in infrastructure, intellectual and human capital has positioned Singapore as a leading international bio-cluster in Asia.

As a result, more than 4,300 researchers now carry out biomedical research in both the private and public sectors in Singapore, he said.

The sector has been enjoying a boom of sorts recently.

Last year, the sector’s manufacturing output rose 2.5 per cent year-on-year to $20 billion. Singapore aims for the sector to hit a manufacturing output of $25 billion by 2015.

     
  Ask the Specialists - Free Doctor Q&A  
    Previous Q&As
Check out our archive for all our previous doctor's Q&As!
*Latest Update: About LASIK
 
e-Appointment Online
Health Buddy App